Assessment of DNA-PKcs kinase activity by quantum dot-based microarray

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Cancer therapy efficacy relies on inducing DNA lesions like double-strand breaks (DSBs).
• DNA repair pathways, particularly non-homologous end joining (NHEJ), can confer resistance in tumor cells.
• DNA repair proteins are emerging as crucial targets for enhancing anticancer treatments.

Purpose of the Study:

• To develop a high-throughput screening tool for identifying effective kinase inhibitors.
• To evaluate the therapeutic potential of targeting DNA-PKcs, a key protein in NHEJ.
• To assess the modification of phosphoproteomic profiles in response to DNA damage and inhibitors.

Main Methods:

• Elaboration of an antibody microarray specifically designed for the NHEJ pathway.
• Utilizing a protein microarray combined with Quantum-Dot detection.
• Evaluating DNA-PKcs kinase activity in response to DNA damage and potential inhibitors.

Main Results:

• Demonstrated the capability to monitor phosphoproteomic changes induced by inhibitors during DNA damage response.
• Successfully employed an antibody microarray to assess DNA-PKcs kinase activity.
• Showcased the utility of the developed tool for evaluating kinase inhibitor efficacy.

Conclusions:

• The developed antibody microarray is a promising tool for screening kinase inhibitors.
• Targeting DSB repair pathways, specifically via DNA-PKcs inhibition, holds potential for improving cancer treatment.
• This approach facilitates the identification of sensitizing molecules to enhance anticancer therapy effectiveness.